H&T Presspart is pleased to announce we will be sponsoring this year’s RDD Asia conference, which is taking place in Kerala, India, from the 19-21st November, 2024.

As part of this sponsorship, H&T Presspart’s Dr. Anselm Ebert, Business Development Director, and Ameet Sule, Director of Inhalation Product Technology Centre, will be hosting a workshop entitled ‘The Future of Sustainable Inhalation Devices: MDIs and DPIs’.

Also, during the conference, we will also be presenting a scientific poster from our Inhalation Product Technology Centre team entitled ‘Designing a Sustainable Ipratropium HFA-152a pMDI: Actuator Geometry Considerations’. The poster will use analytical data on low GWP propellant MDIs which has been generated by our IPTC team.

H&T Presspart will also be exhibited at this year’s RDD Asia, where we will be showcasing our full range of metered-dose inhaler components, including MDI cans and actuators, as well as our range of dose counting solutions. Also, on the stand will be our range of dry powder inhalers, including PowdAir Plus and our high performance Sunriser DPI device,

Jointly organized by RDD Online and Aptar Pharma, RDD Asia 2024 represents the extension of US and European RDD meetings into one of the world’s prominent emerging markets and hotbed of inhaler development. The conference will feature lively, fresh and focused updates on respiratory drug delivery in Asia and the rest of the world, and will serve as a bridge to support academic collaboration, international regulatory harmonization and commercial development across continents.

If you are attending RDD Asia and would like to arrange a meeting then please contact the team.